Objectives: To compare efficacy and safety of 50 mg vaginal Misoprostol with transcervical Foley's catheter and intravenous oxytocin for labor induction. Method(S): 150 women at term gestation, with Bishop score < 4, with various indications for labor induction were randomly allocated to receive either Misoprostol vaginally'6 hourly (maximum 4 doses) or transcervical Foley's catheter with intravenous oxytocin (2 mU/minute to a maximum of 32 mU/minute or till the woman goes into active labour). Results: In Misoprostol group induction-delivery interval was significantly less (11.58 vs 19.45 hours) and successful induction significantly higher (98% vs 78%) as compared to catheter/oxytocin group. Eighty-eight percent of the women delivered within 24 hours of induction in misoprostol group whereas in the other group 72% delivered within 24 hours. Eighteen percent of women delivered with a single dose of misoprostol while 28% required the maximum dosages of oxytocin.
INTRODUCTION
Modern obstetrics aims at improving the safety of the mother and the fetus during antenatal period as well as parturition. The aim of induction of labour is to perform safe vaginal delivery. Spontaneous labour and vaginal delivery is preceded by a cascade of synchronized events, which leads to ripening of cervix/'\ Induction is the process of starting labour by uterine stimulation. It should be used when it is thought that the baby will be saferto deliver than in utero.
From 15% to 20% of all pregnancies require induction of labour "\ Many women who require induction of labour present with an "unripe" cervix^.
Labour induction in the presence of an unfavorable cervix is professional folley and associated with prolonged labor and increased incidence of chorioamnionitis and cesarean section. Hence, the use of cervical ripening agents prior to conventional methods of induction is now a standard practice * \ Moving preinduction cervical ripening from an inpatient to an outpatient setting appears to decrease cost significantly^. Furthermore, 50% of all patients requiring induction of labour may be eligible for outpatient cervical ripening (4 
MATERIALS & METHODS
The protocol of this study was approved by the local ethical committee of the institution and all participants consented before inclusion in the study. We excluded women with uterine surgeries, multifetal gestation, nonreassuring fetal heart tracings, thyrotoxicosis, heart disease, bronchial asthma and known hypersensitivity to prostaglandins.
The participants were assigned to two groups (woman's choice).
The First: 
Statistical analysis
Median and range were computed. Continuous variables were compared using the Fisher's Z test and discrete data with the c2 test. Analysis was performed using statistical software SPSS version 13.
Maternal demographic characteristics and indications for induction were similar in the two groups (Table I) (Table II) . With Misoprostol, four hyperstimulation occurred while one was seen in the catheter/oxytocin group (Table II) (Table III) .
There were no significant differences in the neonatal outcomes between the two groups. All the neonates were born alive with Apgar score of nine at five minutes. But a woman in the second group lost her fetus by meconium aspiration. Only 4 babies in oxytocin group and two in Misoprostol group required admission to the neonatal intensive care unit (Table IV) . We concluded that vaginal Misoprostol is highly effective, easy to administer and superior to catheter/oxytocin in cervical ripening and induction of labour.
